Inventor
Camellia W. Adams
Inventor
Mountain View, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes4%
C12NMicroorganisms or enzymes3%
C40BCombinatorial chemistry1%
H01LSemiconductor devices1%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h101%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h101%
PatentTitleYear
11,069,551Method of dampening a force applied to an electrically-actuatable element20218,642,740'Antibodies to lymphotoxin-alpha'20148,562,992'Immunoglobulin variants and uses thereof'20138,541,552'Antibodies to lymphotoxin-α'20138,409,570'Method of inducing apoptosis using anti-DR5 antibodies'20138,216,807'Antibodies to lymphotoxin-α'20128,092,799'Antibodies to Apo-2 receptor polypeptides'20128,030,023'Nucleic acid encoding DR5 antibodies and uses thereof'20118,029,783'DR5 antibodies and articles of manufacture containing same'20118,012,482'Humanized anti-TGF-beta antibodies'20117,923,011'Antibodies to lymphotoxin-alpha'20117,862,817'Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies'20117,807,153'Apo-2 receptor agonist antibodies'20107,799,900'Immunoglobulin variants and uses thereof'20107,595,046'Treatment of cancer using anti-Apo-2 antibodies'20097,537,931'Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies'20097,527,791'Humanized anti-TGF-beta antibodies'20097,501,122'Treatment with anti-ErbB2 antibody combinations'20097,498,030'Treatment with anti-ErbB2 antibodies and anti-hormonal compounds'20097,485,302'Treatment with anti-ErbB2 antibodies and chemotherapeutic agents'20097,354,585'Methods of treating coagulapathic or thrombotic disorders'20087,314,619'Inducing apoptosis using anti-Apo-2 antibodies'20087,049,411'Human anti-factor IX/IXa antibodies'20066,737,249'Agonist antibodies'20046,624,295'Human anti-factor IX/IXa antibodies'20036,342,220'Agonist antibodies'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2014Patents assigned to GENENTECH INC (25)· patent assignee history
2002–2014Based in Mountain View, CA, US· patent location history
2003–2008Based in Mountainview, CA, US· patent location history
2009–2013Based in San Jose, CA, US· patent location history
2012–2014Patents assigned to ADAMS CAMELLIA W (6)· patent assignee history
2012–2014Patents assigned to GROGAN JANE L (3)· patent assignee history
2012–2014Patents assigned to GURNEY AUSTIN L (3)· patent assignee history
2012–2014Patents assigned to MCCUTCHEON KRISTA (3)· patent assignee history
2021Based in Coeur d'Alene, ID, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 25 | 2002–2014 |
| ADAMS CAMELLIA Wself | 6 | 2012–2014 |
| GROGAN JANE L | 3 | 2012–2014 |
| GURNEY AUSTIN L | 3 | 2012–2014 |
| MCCUTCHEON KRISTA | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mountain View, California, US | 15 | 2002–2014 |
| San Jose, California, US | 7 | 2009–2013 |
| Mountainview, California, US | 3 | 2003–2008 |
| Coeur d'Alene, ID, US | 1 | 2021 |